ATC
BBNX

Adirondack Trust Company’s Beta Bionics BBNX Stock Holding History

Adirondack Trust Company’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45K Buy
+603
New +$7.17K ﹤0.01% 420

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Adirondack Trust Company's BBNX Position: Q2 2026 in Review

Adirondack Trust Company opened a new position in Beta Bionics (BBNX) in Q2 2026: 603 shares worth $9.45K. The stake represents ﹤0.01% of the portfolio and ranks #420 among its holdings.

16 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Adirondack Trust Company held 603 shares of Beta Bionics worth $9.45K as of Q2 2026.
  • Beta Bionics was a new Adirondack Trust Company position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #420 holding.
  • 16 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.